a, b JEG-3 cells infected with 0.1 MOI of r-MRV for 48 h showed significant increase in apoptosis as evidenced by caspase 3/7 activity and percent apoptotic nuclear compared to uninfected vehicle treatment. ZIKV-induced placental trophoblast apoptosis were significantly prevented in JEG-3 cells infected with 0.1 MOI of r-MRV and IREi (STF-083010, IRE1α inhibitor), JNKi (SP600125, JNK inhibitor), or ZVAD (Z-VAD-fmk, pan caspase inhibitor) treatment, respectively. However, ZIKV infection and treatment of Sal (Salubrinal, eIF2α dephosphorylation inhibitor) did not prevent trophoblast apoptosis. c, d HTR-8 cells infected with 0.1 MOI of r-MRV for 72 h showed a dramatic increase in biochemical markers of apoptosis compared to uninfected vehicle cells. ZIKV-induced placental trophoblast apoptosis were significantly prevented in HTR-8 cells infected with 0.1 MOI of r-MRV and Sal (Salubrinal, eIF2α dephosphorylation inhibitor), JNKi (SP600125, JNK inhibitor), or ZVAD (Z-VAD-fmk, pan caspase inhibitor) treatment, respectively. However, ZIKV infection and IRE inhibition (STF-083010, IRE1α inhibitor) or p38 inhibition treatment does not prevent ZIKV-induced trophoblast apoptosis. e JAR cells infected with 0.1 MOI r-MRV 48 h postinfection showed activation of caspase 3/7 when compared to vehicle cells. Sal (Salubrinal, eIF2α dephosphorylation inhibitor), JNKi (SP600125, JNK inhibitor), or ZVAD (Z-VAD-fmk, pan caspase inhibitor) treatment in infected cells inhibited caspase 3/7 activation while p38 inhibition significantly increased caspase 3/7 activation. Each value presents mean ± SEM of (n = 4) for caspase 3/7 activity and n = 3 for percent apoptotic nuclei, *P < 0.05 compared to uninfected vehicle cells; #P < 0.05 compared to ZIKV infected cells; statistical comparison by ANOVA with posthoc Bonferroni correction.